DB

Dinesh Bhati

Active Director Director DIN 11159242
DIN 11159242 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Dinesh Bhati

Data last updated:

Dinesh Bhati is a Director at Ambumed Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 11159242
Primary Designation Director
Industry Pharma
First Appointment 19 Jun 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ambumed Pharma Private Limited U21001TS2024PTC183695
Director19 Jun 20252024Active

Directorship timeline

Open interactive timeline →
Ambumed Pharma Private Limited
Premium access

Shareholding and investment profile for Dinesh Bhati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dinesh Bhati

Dinesh Bhati currently holds 1 directorship: Ambumed Pharma Private Limited (Director, since 19 Jun 2025).

Dinesh Bhati was first appointed on 19 Jun 2025 as Director at Ambumed Pharma Private Limited.

The current boards of Dinesh Bhati's companies include Ashok Bhati (Ambumed Pharma Private Limited), Mahesh Kumar Toshniwal (Ambumed Pharma Private Limited), Manoj Kumar Bhati (Ambumed Pharma Private Limited), Pradeep Kumar Sharma (Ambumed Pharma Private Limited), Radheshyam Bhati (Ambumed Pharma Private Limited), Ram Kumar Bhati (Ambumed Pharma Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available